Historical Stock Price
ETFs Holding ACRS »    Stock Splits Calendar »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
08/06/2020 $2.15 $2.24 $1.92 $1.95 621.60K
08/07/2020 $1.90 $2.14 $1.82 $2.10 467.10K
08/10/2020 $2.10 $2.23 $2.07 $2.17 522.60K
08/11/2020 $2.25 $2.70 $2.14 $2.28 2.50M
08/12/2020 $2.33 $2.46 $2.20 $2.20 523.80K
Aclaris Therapeutics is a biopharmaceutical company focused on immuno-inflammatory diseases. Co.'s pipeline of drug candidates includes: ATI-450 mitogen-activated protein kinase-activated protein kinase 2 Inhibitor Oral for the indication of Rheumatoid Arthritis plus Additional Immuno-inflammatory Indication; and ATI-1777 Janus kinase (JAK)1/JAK3 Inhibitor Soft Topical for the indication of Atopic Dermatitis. ESKATA, Co.'s only U.S. Food and Drug Administration (FDA)-approved product, is a formulation of high-concentration hydrogen peroxide topical solution which is approved by the FDA as an office-based prescription treatment for raised seborrheic keratosis, a non-malignant skin tumor.
ACRS historical stock prices picture
Aclaris Therapeutics (ACRS) has the following price history information. Looking back at ACRS historical stock prices for the last five trading days, on August 06, 2020, ACRS opened at $2.15, traded as high as $2.24 and as low as $1.92, and closed at $1.95. Trading volume was a total of 621.60K shares. On August 07, 2020, ACRS opened at $1.90, traded as high as $2.14 and as low as $1.82, and closed at $2.10. Trading volume was a total of 467.10K shares. On August 10, 2020, ACRS opened at $2.10, traded as high as $2.23 and as low as $2.07, and closed at $2.17. Trading volume was a total of 522.60K shares. On August 11, 2020, ACRS opened at $2.25, traded as high as $2.70 and as low as $2.14, and closed at $2.28. Trading volume was a total of 2.50M shares. On August 12, 2020, ACRS opened at $2.33, traded as high as $2.46 and as low as $2.20, and closed at $2.20. Trading volume was a total of 523.80K shares.

ACRS Historical Stock Prices By Date:

ACRS historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Aclaris Therapeutics shares, starting with a $10,000 purchase of ACRS, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/06/2015
End date: 08/12/2020
Start price/share: $11.00
End price/share: $2.20
Dividends collected/share: $0.00
Total return: -80.00%
Average Annual Total Return: -28.22%
Starting investment: $10,000.00
Ending investment: $1,999.52
Years: 4.85
Date Close
08/06/2020$1.95
08/07/2020$2.10
08/10/2020$2.17
08/11/2020$2.28
08/12/2020$2.20
ACRS is categorized under the Healthcare sector; below are some other companies in the same sector:

ACRX Historical Stock Prices
ACST Historical Stock Prices
ACT Historical Stock Prices
ACUR Historical Stock Prices
ADHD Historical Stock Prices
ADK Historical Stock Prices
ADMA Historical Stock Prices
ADMP Historical Stock Prices
ADMS Historical Stock Prices
ADPT Historical Stock Prices

Also explore: ACRS shares outstanding history

ACRS Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2020, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.